The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCL.L Regulatory News (MCL)

  • There is currently no data for MCL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

4 Oct 2022 13:03

RNS Number : 7458B
Morses Club PLC
04 October 2022
 

 4 October 2022

Morses Club PLC

Result of Annual General Meeting

Morses Club PLC is pleased to announce that all resolutions proposed at the Company's Annual General Meeting, held at 10.30am today, were duly approved by shareholders. The resolutions and voting outcomes are set out below:

 

IN FAVOUR

AGAINST

VOTES WITHHELD

Number of

Shares

% Voting Shares

Number of

Shares

% Voting Shares

Number of Shares

RESOLUTION

1.

Report and Accounts

33,708,555

99.79%

71,638

0.21%

0

2.

Remuneration Report

33,560,212

99.43%

192,717

0.57%

27,264

3.

Re-elect Sir Nigel Knowles

33,530,394

99.26%

249,799

0.74%

0

4.

Re-elect Sheryl Lawrence

33,595,594

97.45%

184,599

0.55%

0

5.

Re-elect Michael Yeates

33,530,594

99.26%

249,599

0.74%

0

6.

Re-elect Peter Ward

33,530,594

99.26%

249,599

0.74%

0

7.

Re-elect Graeme Campbell

33,530,594

99.26%

249,599

0.74%

0

8.

Re-elect Gary Marshall

33,530,594

99.26%

249,599

0.74%

0

9.

Re-appoint auditor

33,752,552

99.92%

25,474

0.08%

2,167

10. 

Remuneration of auditor

33,696,281

99.75%

83,912

0.25%

0

11. 

Authority to allot shares

33,697,243

99.75%

82,950

0.25%

0

12. 

Authority to disapply pre-emption rights (Special Resolution)

33,689,345

99.73%

90,848

0.27%

0

13. 

Authority for company to purchase its own shares (Special Resolution)

33,708,381

99.79%

71,812

0.21%

0

 

Notes:

1. Percentage of voting shares is the percentage of shares voted and excludes shares on which votes were withheld

2. Total number of shares voted = 33,780,193 (25.1%)

3. Total number of shares in issue = 134,431,518

 

EndsFor further information please contact:

 

Morses Club PLC Gary Marshall, Chief Executive OfficerGraeme Campbell, Chief Financial Officer

Tel: +44 (0) 330 045 0719

Peel Hunt (Nomad)Paul Shackleton / Andrew Buchanan / Sam Milford (Investment Banking Division)

 

Tel: +44 (0) 20 7418 8900

CamarcoJennifer Renwick / Charlotte Hollinshead

Tel: +44 (0) 20 3757 4994

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUPGCAUUPPGGC
Date   Source Headline
13th Feb 20237:00 amRNSCancellation - Morses Club PLC
10th Feb 20235:59 pmRNSDirector/PDMR Shareholding
10th Feb 20234:40 pmRNSSecond Price Monitoring Extn
10th Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20234:40 pmRNSSecond Price Monitoring Extn
7th Feb 20234:35 pmRNSPrice Monitoring Extension
6th Feb 20235:30 pmRNSMorses Club
3rd Feb 202311:11 amRNSResult of General Meeting
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20237:00 amRNSExtension of Term-Out Clause
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 202312:42 pmRNSHolding(s) in Company
13th Jan 20237:00 amRNSHolding(s) in Company
12th Jan 20237:00 amRNSProposed Cancellation of Ordinary Shares
15th Dec 20227:00 amRNSExtension of Term-Out Clause
13th Dec 20227:00 amRNSIssue of PSL and update on Scheme of Arrangement
30th Nov 20224:41 pmRNSSecond Price Monitoring Extn
30th Nov 20224:36 pmRNSPrice Monitoring Extension
24th Nov 20227:00 amRNSInterim Results
16th Nov 20222:41 pmRNSHolding(s) in Company
15th Nov 20227:00 amRNSUpdate on Peak Advance Funding
3rd Nov 20227:00 amRNSBoard Appointments
4th Oct 20221:03 pmRNSResult of AGM
4th Oct 20227:00 amRNSBoard Changes
30th Sep 20227:00 amRNSTrading Update
28th Sep 202212:53 pmRNSFurther Update on Potential Scheme of Arrangement
21st Sep 20224:40 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSUpdate on Funding Arrangements
25th Aug 20227:00 amRNSPreliminary results - 26 February 2022
15th Aug 20227:00 amRNSResults Update
11th Aug 20227:00 amRNSUpdate on Potential Scheme of Arrangement
22nd Jul 20224:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20224:35 pmRNSPrice Monitoring Extension
20th Jul 20227:00 amRNSPotential Scheme of Arrangement & Financial Update
21st Jun 20227:00 amRNSUpdate on Claims Volumes and FY22 Results
25th May 20227:00 amRNSFY 22 Results Update
17th May 20222:39 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSTrading Update
22nd Feb 20224:29 pmRNSAIM Rule 17 Disclosure
21st Feb 20227:01 amRNSPDMR Dealing
21st Feb 20227:00 amRNSTrading Update and Director Changes
28th Jan 20222:17 pmRNSPDMR Dealing
22nd Dec 20217:00 amRNSBoard Changes
17th Dec 20217:00 amRNSCompany Update
2nd Dec 20217:00 amRNSIssue of Equity
7th Oct 20217:00 amRNSInterim results
14th Sep 20217:00 amRNSUpdate on U Money PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.